Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HCC”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04111029
What this trial is testing

Liquid Biopsy in Hepatocellular Carcinoma

Who this might be right for
Hepatic Carcinoma Malignant Primary Non-Resectable
Post Graduate Institute of Medical Education and Research, Chandigarh 30
Testing effectiveness (Phase 2)UnknownNCT01272557
What this trial is testing

Sorafenib Plus Doxorubicin Versus Sorafenib Alone for the Treatment of Advanced Hepatocellular Carcinoma: a Randomized Phase II Trial

Who this might be right for
Liver Carcinoma
PD Dr. med. Matthias Dollinger 170
Not applicableStudy completedNCT04820712
What this trial is testing

Surgical Therapy and Survival in HCC/ C.F. Zhang et al.

Who this might be right for
Hepatocellular CarcinomaSurgery
Linzhu Zhai 664
Not applicableStudy completedNCT01871545
What this trial is testing

Evaluation of Liver Cancer With Magnetic Resonance Imaging (MRI)

Who this might be right for
Hepatocellular CarcinomaHCC
Icahn School of Medicine at Mount Sinai 84
Not applicableStudy completedNCT06760494
What this trial is testing

Microvascular Invasion Artificial Intelligence Prediction Via Contrast-enhanced Ultrasound With Explainability

Who this might be right for
HCC - Hepatocellular CarcinomaMicrovascular Invasion (MVI)
Chinese PLA General Hospital 250
Not applicableUnknownNCT04076631
What this trial is testing

Surgical Stages of Liver Cirrhosis In Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver Cirrhosis
Chen Xiaoping 1,000
Not applicableEnded earlyNCT02787954
What this trial is testing

Prospective Tumor Response Evaluation

Who this might be right for
Hepatocellular CancerMetastatic Liver Cancer
The University of Texas Health Science Center, Houston 10
Not applicableUnknownNCT03708705
What this trial is testing

Liquid Biopsy-based Monitoring System for Relapse of HCC After Liver Transplantation: A Multi-center and Prospective Study

Who this might be right for
Hepatocellular Carcinoma
Zhejiang University 500
Not applicableUnknownNCT04967495
What this trial is testing

TACE Plus Multikinase Inhibitor and I-125 Seeds Brachytherapy for HCC With Branch PVTT

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 171
Large-scale testing (Phase 3)Study completedNCT00617981
What this trial is testing

Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Imunon 701
Not applicableStudy completedNCT02031952
What this trial is testing

Hepatectomy Versus Hepatectomy With Lymphadenectomy in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 87
Testing effectiveness (Phase 2)Study completedNCT01545804
What this trial is testing

Lenalidomide as Second-line Treatment for Advanced Hepatocellular Carcinoma

Who this might be right for
Liver Cancer
National Taiwan University Hospital 55
Testing effectiveness (Phase 2)Study completedNCT04962958
What this trial is testing

Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery

Who this might be right for
CarcinomaCarcinoma, HepatocellularLiver Neoplasms+6 more
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 30
Not applicableStudy completedNCT04823715
What this trial is testing

Transarterial Chemoembolization Plus Hypofractionnated Radiotherapy vs. Surgery in Locally Advanced Hepatocellular Carcinoma: an IPTW Comparison

Who this might be right for
Non-metastatic Hepatocellular Carcinoma
Hospices Civils de Lyon 163
Early research (Phase 1)Study completedNCT00478374
What this trial is testing

Sorafenib With TACE to Treat Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
University of Bern 21
Testing effectiveness (Phase 2)Study completedNCT02471313
What this trial is testing

Integrated Imaging Strategy to Phenotype Progression of Liver Tumors During and After Chemoembolization

Who this might be right for
Liver CancerLiver NeoplasmHepatocellular Carcinoma+1 more
National Institutes of Health Clinical Center (CC) 3
Not applicableUnknownNCT05360420
What this trial is testing

Diagnosis of Nodules ≤2 cm Based on US and CEUS Compared With Current Clinical Procedure

Who this might be right for
Liver CancerLiver Cirrhosis
Tianjin Third Central Hospital 6,730
Early research (Phase 1)Study completedNCT01147380
What this trial is testing

Safety Study of Liver Natural Killer Cell Therapy for Hepatoma Liver Transplantation

Who this might be right for
Liver CirrhosisHepatocellular CarcinomaEvidence of Liver Transplantation
Seigo Nishida 18
Large-scale testing (Phase 3)UnknownNCT05654896
What this trial is testing

Prophylactic Antibiotic Use in Transarterial Chemoembolization for Hepatocellular Carcinoma

Who this might be right for
Antibiotic Prophylaxis
Nadeem Iqbal 158
Not applicableEnded earlyNCT02439008
What this trial is testing

Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response

Who this might be right for
Carcinoma, HepatocellularColorectal NeoplasmsMelanoma+1 more
Centre Oscar Lambret 28
Next Page